THE GLOBAL ALLIANCE FOR TB DRUG DEV INC has a total of 41 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CAPULUS THERAPEUTICS LLC, TEMPEST THERAPEUTICS INC and ANGEX PHARMACEUTICAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 7 | |
#3 | Brazil | 4 | |
#4 | Canada | 4 | |
#5 | China | 4 | |
#6 | EPO (European Patent Office) | 4 | |
#7 | Republic of Korea | 4 | |
#8 | South Africa | 3 | |
#9 | Hong Kong | 2 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kaneko Takushi | 17 |
#2 | Fotouhi Nader | 17 |
#3 | Huang Haihong | 9 |
#4 | Cooper Christopher B | 8 |
#5 | Mendel Cari M | 8 |
#6 | Upton Anna Marie | 7 |
#7 | Nuermberger Eric | 7 |
#8 | Van Den Broeck Walter Marcel Mathilde | 7 |
#9 | Cooper Christopher Blair | 7 |
#10 | Ma Zhenkun | 7 |
Publication | Filing date | Title |
---|---|---|
WO2021062316A1 | Azaindole carboxamide compounds for the treatment of mycobacterial infections | |
WO2021062318A1 | Thiazole carboxamide compounds and use thereof for the treatment of mycobacterial infections | |
WO2021062319A1 | Indole carboxamide compounds and use thereof for the treatment of mycobacterial infections | |
WO2021016012A1 | Pretomanid compositions | |
CN110035661A | For treating the heteroaryl trifluoroborate compound of mycobacterial infections | |
CN109069514A | Antimicrobial compound and application thereof | |
WO2017066053A1 | Combination antibacterial composition and short-course antibacterial regimen | |
CN108348507A | It is substituted phenyl oxazolidinones for antimicrobial therapy |